143 related articles for article (PubMed ID: 36705596)
21. Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.
Mirzazadeh S; Bemani P; Halimi H; Sanaee MN; Karami N; Ramzi M; Farjadian S
Sci Rep; 2023 Jul; 13(1):11456. PubMed ID: 37454198
[TBL] [Abstract][Full Text] [Related]
22. Genetic polymorphism analysis of killer cell immunoglobulin-like receptor genes in the Chinese Uygur population.
Wang HD; Zhu BF; Shen CM; Yuan GL; Yang G; Guo JN; Yan JW; Qin HX; Guo JX; Zhang LP; Jia XQ; Lucas R
Mol Biol Rep; 2012 Mar; 39(3):3017-28. PubMed ID: 21701829
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory natural killer cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians.
Maruthamuthu S; Rajalingam R; Pandian K; Madasamy S; Manoharan M; Pitchai L; Murugesan A; Mariakuttikan J
AIDS; 2018 Nov; 32(18):2679-2688. PubMed ID: 30289808
[TBL] [Abstract][Full Text] [Related]
24. The effects of killer cell immunoglobulin-like receptor (KIR) genes on susceptibility to HIV-1 infection in the Polish population.
Zwolińska K; Błachowicz O; Tomczyk T; Knysz B; Gąsiorowski J; Zalewska M; Orzechowska BU; Sochocka M; Piasecki E
Immunogenetics; 2016 May; 68(5):327-37. PubMed ID: 26888639
[TBL] [Abstract][Full Text] [Related]
25. KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease.
Levinson RD; Yung M; Meguro A; Ashouri E; Yu F; Mizuki N; Ohno S; Rajalingam R
PLoS One; 2016; 11(8):e0160392. PubMed ID: 27490240
[TBL] [Abstract][Full Text] [Related]
26. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.
Naumova E; Mihaylova A; Stoitchkov K; Ivanova M; Quin L; Toneva M
Cancer Immunol Immunother; 2005 Feb; 54(2):172-8. PubMed ID: 15248031
[TBL] [Abstract][Full Text] [Related]
27. Distribution of HLA-A, -B, and -C alleles and HLA/KIR combinations in Han population in China.
Shen Y; Cao D; Li Y; Kulski JK; Shi L; Jiang H; Ma Q; Yu J; Zhou J; Yao Y; Shi L
J Immunol Res; 2014; 2014():565296. PubMed ID: 24995346
[TBL] [Abstract][Full Text] [Related]
28. KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR GENES AND THEIR HLA-C LIGANDS IN HASHIMOTO THYROIDITIS IN A CHINESE POPULATION.
Li JT; Guo C; Li ML; Wei YQ; Hou YF; Jiao YL; Zhao YR; Sun H; Xu J; Cao MF; Feng L; Yu GN; Gao L; Liu YQ; Zhang BC; Zhao JJ; Zhang HQ
Endocr Pract; 2016 Aug; 22(8):935-40. PubMed ID: 27042744
[TBL] [Abstract][Full Text] [Related]
29. Genetic profiles of killer-cell immunoglobulin-like receptors and HLA ligands in Thai blood donors.
Kitpoka P; Tammakorn C; Chaisri S; Leelayuwat C; Mongkolsuk T; Thammanichanond D
Hum Immunol; 2016 Jun; 77(6):470-5. PubMed ID: 27131859
[TBL] [Abstract][Full Text] [Related]
30. Impact of "Killer Immunoglobulin-Like Receptor /Ligand" Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival.
Beksac K; Beksac M; Dalva K; Karaagaoglu E; Tirnaksiz MB
PLoS One; 2015; 10(7):e0132526. PubMed ID: 26181663
[TBL] [Abstract][Full Text] [Related]
31. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
[TBL] [Abstract][Full Text] [Related]
32. Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.
Jobim M; Chagastelles P; Salim PH; Portela P; Wilson TJ; Curti AG; Jobim MR; João DA; Nardi NB; Tschiedel B; Jobim LF; Roesler R; Schwartsmann G
Hum Immunol; 2010 Aug; 71(8):799-803. PubMed ID: 20580654
[TBL] [Abstract][Full Text] [Related]
33. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.
Karlsen TH; Boberg KM; Olsson M; Sun JY; Senitzer D; Bergquist A; Schrumpf E; Thorsby E; Lie BA
J Hepatol; 2007 May; 46(5):899-906. PubMed ID: 17383044
[TBL] [Abstract][Full Text] [Related]
34. Genetic profile of KIR and HLA in southern Chinese Han population.
Zhen J; Wang D; He L; Zou H; Xu Y; Gao S; Yang B; Deng Z
Hum Immunol; 2014 Jan; 75(1):59-64. PubMed ID: 24055695
[TBL] [Abstract][Full Text] [Related]
35. KIR genotyping in the selected population in Andhra Pradesh (India).
Vaishnav G; Krupanidhi S; Sanjeevi CB
Roum Arch Microbiol Immunol; 2014; 73(1-2):43-50. PubMed ID: 25518570
[TBL] [Abstract][Full Text] [Related]
36. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
[TBL] [Abstract][Full Text] [Related]
37. Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires.
Crum KA; Logue SE; Curran MD; Middleton D
Tissue Antigens; 2000 Oct; 56(4):313-26. PubMed ID: 11098931
[TBL] [Abstract][Full Text] [Related]
38. KIR-HLA gene diversities and susceptibility to lung cancer.
Hematian Larki M; Ashouri E; Barani S; Ghayumi SMA; Ghaderi A; Rajalingam R
Sci Rep; 2022 Oct; 12(1):17237. PubMed ID: 36241658
[TBL] [Abstract][Full Text] [Related]
39. Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.
Shastry A; Sedimbi SK; Rajalingam R; Nikitina-Zake L; Rumba I; Wigzell H; Sanjeevi CB
Int J Immunogenet; 2008 Dec; 35(6):439-46. PubMed ID: 19046302
[TBL] [Abstract][Full Text] [Related]
40. Polymorphism of killer cell immunoglobulin-like receptors (KIR) and their HLA ligands in Graves' disease.
Dastmalchi R; Farazmand A; Noshad S; Mozafari M; Mahmoudi M; Esteghamati A; Amirzargar A
Mol Biol Rep; 2014 Aug; 41(8):5367-74. PubMed ID: 24852304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]